Journal of Health Care Compliance
Looking Ahead: DOJ Enforcement Priorities in 2025
November – December 2024
In 2024, the Department of Justice (DOJ) continued to emerge from a pandemic lull and return to vigorous enforcement of the False Claims Act (FCA) — indeed in February, DOJ announced that it had issued a record 1,504 civil investigative demands in fiscal year 2023, and its current activity levels suggest another record-breaking year. In 2025, the healthcare industry can expect that DOJ will continue to prioritize investigating alleged fraud, waste, and abuse in the industry, with particular attention paid to private equity investment, the Anti-Kickback Statute (AKS), pandemic relief fraud, and cyber fraud.
Contacts
Related Blogs
Capabilities
Suggested News & Insights
DOJ Announces $13 Million Settlement with Defense and Aerospace Contractors, Alleging Failures to Meet Cybersecurity RequirementsNovember 11, 2026DOJ and EEOC Announce $29.5 Million Two-Part Settlement with Lockheed Martin, the Fourth FCA Resolution Targeting Alleged Employment DiscriminationNovember 5, 2026District of Massachusetts Rejects Per Se AKS Liability for Commissioned, Independent Contractor Sales Representatives But Allows FCA Claims to ProceedOctober 26, 2026DOJ Launches Criminal and Civil Self-Disclosure Programs Relevant to Healthcare and Life Sciences CompaniesOctober 26, 2026DOJ and HHS Launch Healthcare FCA Self-Disclosure Pilot Program with Fixed Repayment MultiplierOctober 22, 2026HHS Secretary Extends HHS-OIG Exclusion Authority to CMS, Expanding the Administration's Anti-Fraud CampaignOctober 19, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
